Data have been deposited in the NCBI sequence read archive under PRJNA494103 (<https://www.ncbi.nlm.nih.gov/bioproject/PRJNA494103>).

Introduction {#sec001}
============

Transposable elements (TEs) are ubiquitous mobile genetic entities, whose unrestricted propagation can cause deleterious insertional mutations and chromosome rearrangements, and are often associated with cancer and sterility \[[@pgen.1008861.ref001]--[@pgen.1008861.ref004]\]. TE regulation is therefore essential, especially in germline cells, where TE insertions and associated mutations can be transmitted to the next generation. In metazoan germlines, regulation of TE transcripts is enacted by a small RNA silencing pathway, the PIWI-interacting RNA pathway (piRNA pathway), in which piRNAs complexed with PIWI-clade Argonaute proteins target complementary TEs for post-transcriptional and transcriptional silencing \[[@pgen.1008861.ref005]\].

Host genomes are often parasitized by multiple TE families, which change rapidly in their presence and abundance \[[@pgen.1008861.ref006]--[@pgen.1008861.ref009]\]. The control of TE transcripts by complementary piRNAs may facilitate adaptation to genomic TEs through changes in piRNA species \[[@pgen.1008861.ref010],[@pgen.1008861.ref011]\]. Surprisingly, however, the protein components of the piRNA pathway that enact piRNA biogenesis and enforce TE silencing also evolve adaptively in diverse metazoan lineages \[[@pgen.1008861.ref012]--[@pgen.1008861.ref016]\]. Evidence for adaptive evolution of piRNA pathway proteins is particularly strong in *Drosophila* \[[@pgen.1008861.ref012]--[@pgen.1008861.ref015],[@pgen.1008861.ref017]\], which has also emerged as a work horse for uncovering the mechanisms of piRNA-mediated silencing \[reviewed in [@pgen.1008861.ref018]\]. For example, a recent meta analysis including both *D*. *melanogaster* and *D*. *pseudoobscura* revealed that 22 of 26 piRNA pathway proteins exhibit significant signatures of adaptive protein evolution in one or both species \[[@pgen.1008861.ref014]\].

Adaptive evolution of piRNA effector proteins is proposed to arise from an evolutionary arms race between TEs and host silencing machinery \[reviewed in [@pgen.1008861.ref019]\]. In the simplest scenario, effector proteins evolve adaptively in order to restore silencing of newly invading or escaper TE families. Alternatively, if TEs "fight back" by encoding RNA or protein antagonists of host silencing machinery, piRNA pathway proteins could evolve adaptively to escape TE antagonism \[[@pgen.1008861.ref020]\]. Finally, piRNA proteins may evolve adaptively to avoid "genomic auto-immunity" in the form of off-target silencing of host genes \[[@pgen.1008861.ref019],[@pgen.1008861.ref021]\]. Uncovering which of these selective forces drives the adaptive evolution of piRNA effector proteins requires elucidating the resulting functional consequences of piRNA-effector-protein divergence. For example, adaptive evolution among transcriptional silencers has led to incompatibilities between alleles of interacting proteins from different species, with dramatic consequences for piRNA production and TE control \[[@pgen.1008861.ref020],[@pgen.1008861.ref022],[@pgen.1008861.ref023]\]. In particular, functional changes in Rhino are proposed to reflect evolutionary escape from a TE-encoded antagonist \[[@pgen.1008861.ref020]\].

Here, we broaden our understanding of the functional consequences of adaptive evolution among *Drosophila* piRNA effector proteins by examining three additional essential piRNA pathway components that play critical roles in piRNA maturation and post-transcriptional silencing \[[@pgen.1008861.ref024]--[@pgen.1008861.ref030]\]: Armitage (Armi), Aubergine (Aub) and Spindle-E (Spn-E). This work significantly extends a preliminary analysis of Aub divergence \[[@pgen.1008861.ref031]\]. Aub is a Piwi-clade Argonaute protein which, guided by piRNAs, enacts post-transcriptional silencing of sense TE-derived mRNAs \[[@pgen.1008861.ref024]\]. Aub cleavage also feeds forward the ping-pong amplification cycle, a core mechanism for the maturation of both sense and antisense piRNAs that also requires Spn-E \[[@pgen.1008861.ref025],[@pgen.1008861.ref026],[@pgen.1008861.ref028],[@pgen.1008861.ref032]\]. Distinct from both Aub and Spn-E, Armi binds to antisense piRNA precursors to facilitate their sequential cleavage by the nuclease Zucchini in an alternate biogenesis mechanism referred to as "phasing" \[[@pgen.1008861.ref029],[@pgen.1008861.ref033]--[@pgen.1008861.ref037]\]. The loci encoding Aub, Spn-E and Armi all exhibit adaptive evolution along the lineage leading to *D*. *melanogaster*, *D*. *simulans* or both, yet the underlying evolutionary force(s) remain unknown \[[@pgen.1008861.ref013],[@pgen.1008861.ref015]\].

To isolate diverged functions of these adaptively evolving proteins, we performed interspecific complementation, in which we compared the ability of *D*. *melanogaster* and *D*. *simulans* wild-type alleles to complement a *D*. *melanogaster* mutant background. While nuclear transcriptional silencers were previously demonstrated to exhibit dramatic interspecific divergence in TE regulation and piRNA production \[[@pgen.1008861.ref020],[@pgen.1008861.ref023]\], we observed only minor allelic differences in both of these functions. Rather, we uncovered idiosyncratic differences in the regulation of a small handful of TEs, suggesting potential element-specific adaptations. We also observed that *D*. *simulans* alleles of *aub* and *armi* exhibit reduced efficiency of piRNA maturation in association with increased off-target regulation of host mRNAs. We propose that in contrast to nuclear transcriptional silencers, selection acts on cytoplasmic piRNA proteins to maximize their specificity to piRNA production and TE transcripts, while minimizing non-functional or deleterious interactions with host mRNA.

Results {#sec002}
=======

Identifying functional divergence through interspecific complementation {#sec003}
-----------------------------------------------------------------------

Previous divergence-based analyses of Aub and Spn-E suggest that adaptive evolution is not confined to a particular functional domain but is dispersed throughout the proteins \[[@pgen.1008861.ref012],[@pgen.1008861.ref015]\]. Consistent with these findings, we identified abundant amino-acid differences between *D*. *melanogaster* and *D*. *simulans* throughout Aub and Spn-E ([Fig 1A](#pgen.1008861.g001){ref-type="fig"}). Armi does not exhibit strong evidence of positive selection in divergence-based tests, however, an excess of amino acid substitutions exists between *D*. *melanogaster* and *D*. *simulans*, which have likely arisen by positive selection in one or both lineages \[[@pgen.1008861.ref015]\]. Similar to Aub and Spn-E, we observe that these amino acid differences are scattered throughout the protein, both inside and outside of functional domains ([Fig 1A](#pgen.1008861.g001){ref-type="fig"}).

![Functional and sequence divergence in piRNA pathway proteins.\
(A) Amino acid substitutions between *D*. *melanogaster* \[[@pgen.1008861.ref038]\] and *D*. *simulans* \[[@pgen.1008861.ref039]\] reference alleles are indicated as grey tick marks. Starting and ending amino acids for InterPro \[[@pgen.1008861.ref040]\] annotated functional domains are indicated. (B) Female fertility for *D*. *melanogaster* and *D*. *simulans* transgenic rescues are compared for three different age classes. Females with the *D*. *simulans spn-E* transgene are significantly less fertile across the experiment (Repeated measures ANOVA, F~1,172~ = 4.043, *p* \< 0.05) and at the third time point we measured (11--15 days, t~56~ = 2.304, *p* \< 0.05). Females with the *D*. *simulans armi* transgene are significantly less fertile across the experiment (Repeated measures ANOVA, F~1,175~ = 8.824, *p* \< 0.01) and at the second(06--10 days, t~57~ = 3.0718, *p* \< 0.01) and the third time points (11--15 days, t~57~ = 2.5915, *p* \< 0.05). Sample sizes are 25--35 females. \* denotes *p* ≤ 0.05. \*\* denotes *p* ≤ 0.01.](pgen.1008861.g001){#pgen.1008861.g001}

To isolate phenotypic differences between *D*. *melanogaster* and *D*. *simulans* alleles that result from adaptive evolution, we employed interspecific complementation, in which we compared the ability of *D*. *melanogaster* and *D*. *simulans* wild-type alleles to complement a *D*. *melanogaster* mutant background. For each selected piRNA protein, we generated and compared three genotypes: 1) a trans-heterozygous loss-of-function mutant, 2) the same mutant with a *D*. *melanogaster* genomic transgene rescue, and 3) the same mutant with a *D*. *simulans* genomic transgene rescue ([S1 Fig](#pgen.1008861.s001){ref-type="supplementary-material"}). The transgenes include the complete genomic region from either *D*. *melanogaster* or *D*. *simulans*, including upstream and downstream sequences containing potential cis-regulatory elements. Transgenes were inserted into matched *attP* sites by ΦC31 integrase \[[@pgen.1008861.ref041]\], in order to avoid variable position effects. Phenotypes for which the *D*. *simulans* alleles fail to fully complement the mutant, or otherwise differ between the alleles of the two species, point to diverged functions that are potential targets of adaptive evolution.

We first considered the effect of transgenic rescue on female fertility. Homozygosity or trans-heterozygosity for loss of function alleles in all three genes causes complete female sterility ([Fig 1B](#pgen.1008861.g001){ref-type="fig"}, [S1 Table](#pgen.1008861.s010){ref-type="supplementary-material"}), while heterozygotes are fertile \[[@pgen.1008861.ref042]\]. For all three proteins, fertility is restored by transgenic rescues from the two species to different degrees, with *D*. *melanogaster* transgenes conferring higher fertility than their *D*. *simulans* counterparts ([Fig 1B](#pgen.1008861.g001){ref-type="fig"}, [S1 Table](#pgen.1008861.s010){ref-type="supplementary-material"}) \[[@pgen.1008861.ref031]\]. *Drosophila simulans* transgenes do not exhibit significantly reduced expression when compared to *D*. *melanogaster*, in fact for *spn-E* the *D*. *simulans* transgene exhibits a modest 22% increase in expression ([S2 Fig](#pgen.1008861.s002){ref-type="supplementary-material"}). Therefore, reduced fertility effects in the presence of *D*. *simulans* transgenes most likely reflect amino acid sequence divergence in the encoded proteins.

Idiosyncratic differences in TE regulation {#sec004}
------------------------------------------

To uncover molecular phenotypes that relate to fertility differences, we first examined whether *D*. *melanogaster* and *D*. *simulans* alleles differed with respect to TE transcriptional control and associated piRNA production using RNA-seq and small RNA-seq ([S3 Fig](#pgen.1008861.s003){ref-type="supplementary-material"}, [S2 Table](#pgen.1008861.s011){ref-type="supplementary-material"}). Notably, our *D*. *melanogaster* transgenic rescues down-regulated TE transcripts and up-regulated piRNA production similarly to heterozygotes, which are generally considered wild-type with respect to piRNA production and TE silencing ([Fig 2](#pgen.1008861.g002){ref-type="fig"}, [S4 Fig](#pgen.1008861.s004){ref-type="supplementary-material"}, [S3](#pgen.1008861.s012){ref-type="supplementary-material"} and [S4](#pgen.1008861.s013){ref-type="supplementary-material"} Tables). Transgenically expressed *D*. *melanogaster* proteins are therefore fully functional with respect to TE silencing and piRNA biogenesis.

![Minimal differences in TE regulation and piRNA production between alleles.\
TE transcript abundance (A) and TE-derived antisense piRNA abundance (B) is compared between *D*. *melanogaster* rescues and either trans-heterozygous mutants ("*mut*", upper row) or *D*. *simulans* rescues (lower row) for *aub*, *spn-E* and *armi*. Red dashed lines indicate the two fold-change threshold. TE families whose abundance differs substantially between mutants and *D*. *melanogaster* rescues are indicated in red (*p* \< 0.05 for TE transcripts; \>2-fold for piRNA abundance). *P*-values were not considered for small RNA analysis because the small number of TE families in the analysis (\<130 families, [S4 Table](#pgen.1008861.s013){ref-type="supplementary-material"}) is unlikely to provide a sufficiently large sample size for the statistical model implemented in DESeq2 \[[@pgen.1008861.ref043]\]. TE families whose abundance is more than two-fold higher in *D*. *melanogaster* rescues than in *D*. *simulans* rescues are in yellow, whereas the reciprocal is in blue. Total mRNA abundance is from unstranded mRNA sequencing of one biological replicate (*aub*), sense RNA abundance is from stranded RNA sequencing of three biological replicates (*spn-E* and *armi*). TE-derived piRNA abundance is based on two biological replicates for *aub* and three biological replicates for *spn-E* and *armi*, and was normalized to the total number of sequenced miRNAs in the same library.](pgen.1008861.g002){#pgen.1008861.g002}

Enhanced piRNA-mediated negative regulation of TEs is an obvious target of positive selection acting on piRNA pathway proteins. However, sense transcripts for the majority of TEs are not differentially expressed between the transgenic rescues for *armi* and *spn-E*, implying that negative regulation of TEs is largely conserved between species ([Fig 2A](#pgen.1008861.g002){ref-type="fig"}). Similarly, the majority of TEs are not differentially expressed between *aub* transgenic rescues (non-stranded RNA-seq, [Fig 2A](#pgen.1008861.g002){ref-type="fig"}). Nevertheless, despite an overall conservation of TE repression, we discovered idiosyncratic differences in regulation, in which individual TE families are more robustly silenced by the *D*. *melanogaster* or *D*. *simulans* allele. Unexpectedly, 5 out of 5 TE families whose transcript abundance differs between transgenic rescues for one of the three proteins are more robustly silenced by the *D*. *simulans* allele. While differences in TE copy number could arise between transgenes through backcrossing, thereby creating the appearance of differential regulation, this would be equally likely to result in increased or decreased expression in the *D*. *simulans* rescue for any given TE. Thus, the bias towards enhanced negative regulation by *D*. *simulans* is not consistent with the random segregation of polymorphic TE insertion alleles during backcrossing, but rather suggests a true increase in negative regulation by the *D*. *simulans* allele. In particular, the *tirant* LTR retrotransposon is more robustly silenced by the *D*. *simulans* allele of both *aub* and *spn-E*. Furthermore, we did not observe any systematic differences in expression for germline or soma-specific protein-coding genes between the transgenic rescues, strongly suggesting that the germline-to-soma ratio is equivalent between transgenic genotypes ([S2 Fig](#pgen.1008861.s002){ref-type="supplementary-material"}). Differences in silencing of individual TE families therefore suggest lineage-specific coevolution with the host-regulatory machinery.

Divergence in TE regulation between *D*. *melanogaster* and *D*. *simulans* alleles could arise from differential production of complementary antisense piRNAs. Of 5 TE families that are differentially regulated between transgenic rescues for one of the proteins ([Fig 2A](#pgen.1008861.g002){ref-type="fig"}), only *tirant* differential expression between *spn-E* transgenes is associated with a corresponding change in antisense piRNA abundance ([S5 Fig](#pgen.1008861.s005){ref-type="supplementary-material"}). Furthermore, *tirant* antisense piRNAs were increased in the *D*. *melanogaster* transgene, which is not consistent with piRNA loss as the cause of increased TE expression. Similar to their antisense counterparts, the abundances of sense piRNAs, which are produced during post-transcriptional silencing of TE-derived mRNAs, are not systematically different between transgenic rescues for differentially regulated TEs ([S5 Fig](#pgen.1008861.s005){ref-type="supplementary-material"}). Differences in TE negative regulation between alleles therefore occur independently of piRNA production. Furthermore, *D*. *simulans* and *D*. *melanogaster* alleles have very similar effects on the overall pool of TE-derived piRNAs, with only 10 repeat classes differentially abundant for sense or antisense piRNAs for any of the three pairs of transgenic rescues, four of which are satellite repeats (*HETRP*, *HMR1*, *SAR* and *SAR2*, [Fig 2B](#pgen.1008861.g002){ref-type="fig"}, [S5](#pgen.1008861.s005){ref-type="supplementary-material"} and [S6](#pgen.1008861.s006){ref-type="supplementary-material"} Figs). Interspecific divergence in piRNA production is therefore modest between alleles, with no detectable impact on the regulation of genomic TEs.

*Drosophila simulans* alleles exhibit reduced piRNA biogenesis {#sec005}
--------------------------------------------------------------

Despite the absence of large-scale interspecific differences in antisense piRNAs that regulate TEs ([Fig 2B](#pgen.1008861.g002){ref-type="fig"}), we interrogated piRNA pools associated with each of the transgenic rescues for evidence of underlying differences in piRNA biogenesis. We examined molecular signatures of the two major mechanisms of piRNA biogenesis: ping-pong and phasing. Ping-pong biogenesis produces piRNAs through reciprocal cleavage of complementary precursors ([Fig 3A](#pgen.1008861.g003){ref-type="fig"}) \[[@pgen.1008861.ref024],[@pgen.1008861.ref025]\]. The frequency of ping-pong amplification is therefore estimated by the fraction of piRNAs occuring on opposite strands of the TE consensus whose sequences overlap by 10 bp, a reflection of the cleavage-site preference of the key ping-pong cycle factors Aub and Argonaute-3 (Ago-3, [Fig 3A--3D](#pgen.1008861.g003){ref-type="fig"}, [S5 Table](#pgen.1008861.s014){ref-type="supplementary-material"}) \[[@pgen.1008861.ref024]--[@pgen.1008861.ref026]\]. In contrast, phasing biogenesis occurs through sequential cleavage of a single RNA strand, which is usually antisense \[[@pgen.1008861.ref033],[@pgen.1008861.ref034]\]. Phasing is detected from the fraction of piRNAs whose 3' ends are immediately followed by a uracil residue (+1-U), as well as the frequency of piRNAs from the same strand that are separated by a distance of a single nucleotide (d1), both of which are diagnostic of cleavage by the phasing nuclease Zucchini ([Fig 3E--3G](#pgen.1008861.g003){ref-type="fig"}, [S6](#pgen.1008861.s015){ref-type="supplementary-material"} and [S7](#pgen.1008861.s016){ref-type="supplementary-material"} Tables) \[[@pgen.1008861.ref033],[@pgen.1008861.ref034]\]. In general, ping-pong and phasing are inversely correlated in mutant piRNA pools, because reducing the frequency of one leads to a proportional increase in the other \[[@pgen.1008861.ref033],[@pgen.1008861.ref034]\].

![*Drosophila simulans* alleles reduce ping-pong biogenesis and phasing biogenesis.\
(A) Simplified diagram of ping-pong amplification loop. (B) Ping-pong fractions of TE-derived piRNAs from 142 TE families are compared between trans-heterozygous mutants and transgenic rescues for *aub* and *spn-E*. (C) Ping-pong fractions of TE-derived piRNAs are compared between trans-heterozygous mutants and transgenic rescues for *armi*. Comparison for 88 and 42 TE families whose ping-pong fractions are decreased (left) or increased (right), respectively, in *armi* mutants as compared to the *D*. *melanogaster* transgenic rescue. (D) Left: ping-pong fraction heat map for the 20 most piRNA-abundant TE families from panel C left. Right: ping-pong fraction heat map for 20 most piRNA-abundant TE families from panel C right. (E) Diagram of Zucchini-dependent phased piRNA biogenesis. (F) Proportions of 1 nt distance between adjacent piRNAs (d1) mapped to the TE consensus sequences are compared between each genotype of each gene. (G) Proportions of uridine residues immediately after the 3′ ends of piRNAs (+1-U) mapped to the TE consensus sequences are compared between each genotype of each gene. Statistical significance was assessed by the Wilcoxon signed-rank test. In all panels, for *aub*, two biological replicates of each genotype generated at different times are shown separately. For *spn-E* and *armi*, the average of three biological replicates of each genotype generated at the same time are shown. NS denotes *p* \> 0.05. \*, \*\*, and \*\*\* denote *p* ≤ 0.05, *p* ≤ 0.01, *p* ≤ 0.001, respectively.](pgen.1008861.g003){#pgen.1008861.g003}

Aub plays a direct role in ping-pong amplification by cleaving piRNA precursors ([Fig 3A](#pgen.1008861.g003){ref-type="fig"}) \[[@pgen.1008861.ref024]--[@pgen.1008861.ref026]\], and *spn-E* is required for the localization of Aub into the perinuclear nuage, where ping-pong occurs \[[@pgen.1008861.ref028]\]. Mutations in either gene therefore cause a complete collapse of ping-pong amplification ([Fig 3B](#pgen.1008861.g003){ref-type="fig"}, [S7A and S7B Fig](#pgen.1008861.s007){ref-type="supplementary-material"}, [S5 Table](#pgen.1008861.s014){ref-type="supplementary-material"}) \[[@pgen.1008861.ref026],[@pgen.1008861.ref032]\]. Both *D*. *melanogaster* and *D*. *simulans aub* and *spn-E* alleles exhibited a dramatic increase in the ping-pong fraction, indicating a conserved role in ping-pong biogenesis ([Fig 3B](#pgen.1008861.g003){ref-type="fig"}, [S7A and S7B Fig](#pgen.1008861.s007){ref-type="supplementary-material"}). However in the case of *aub*, ping-pong fractions associated with the *D*. *simulans* transgenic rescue were modestly yet significantly lower than *D*. *melanogaster*, and there was a corresponding proportional increase in phased piRNA biogenesis ([Fig 3B, 3F and 3G](#pgen.1008861.g003){ref-type="fig"}, [S8 Fig](#pgen.1008861.s008){ref-type="supplementary-material"}, [S6](#pgen.1008861.s015){ref-type="supplementary-material"} and [S7](#pgen.1008861.s016){ref-type="supplementary-material"} Tables), suggesting reduced efficiency of ping-pong. By contrast, *D*. *simulans spn-E* allele did not reduce ping-pong ([Fig 3B](#pgen.1008861.g003){ref-type="fig"}, [S7B Fig](#pgen.1008861.s007){ref-type="supplementary-material"}, [S5 Table](#pgen.1008861.s014){ref-type="supplementary-material"}), yet there was a modest but significant increase in the d1 proportion with the *D*. *simulans spn-E* rescue ([Fig 3F](#pgen.1008861.g003){ref-type="fig"}, [S6 Table](#pgen.1008861.s015){ref-type="supplementary-material"}), potentially suggesting increased phasing.

Armi promotes the production of phased piRNAs by binding to antisense piRNA intermediates and facilitating their cleavage by the nuclease Zucchini ([Fig 3E](#pgen.1008861.g003){ref-type="fig"}) \[[@pgen.1008861.ref029],[@pgen.1008861.ref033],[@pgen.1008861.ref034]\]. Both d1 and +1-U are therefore significantly reduced in *armi* mutants ([Fig 3F and 3G](#pgen.1008861.g003){ref-type="fig"}, [S8 Fig](#pgen.1008861.s008){ref-type="supplementary-material"}, [S6](#pgen.1008861.s015){ref-type="supplementary-material"} and [S7](#pgen.1008861.s016){ref-type="supplementary-material"} Tables). While Armi is not involved in ping-pong, phasing produces Aub-bound antisense piRNAs, which are required for ping-pong biogenesis for some TE families \[[@pgen.1008861.ref026],[@pgen.1008861.ref044]\]. Ping-pong fractions are therefore decreased in *armi* mutants for some TE families ([Fig 3C and 3D](#pgen.1008861.g003){ref-type="fig"}, [S7C Fig](#pgen.1008861.s007){ref-type="supplementary-material"}, [S5 Table](#pgen.1008861.s014){ref-type="supplementary-material"}). By contrast, for TE families that do not rely on phased piRNA production for ping-pong, ping-pong-derived piRNAs proportionally increase in *armi* mutants, owing to the loss of phased piRNAs ([Fig 3C and 3D](#pgen.1008861.g003){ref-type="fig"}, [S7C Fig](#pgen.1008861.s007){ref-type="supplementary-material"}, [S5 Table](#pgen.1008861.s014){ref-type="supplementary-material"}). Although exhibiting piRNA production similar to the *D*. *melanogaster* allele ([Fig 2B](#pgen.1008861.g002){ref-type="fig"}), the *D*. *simulans armi* rescue exhibited modestly but significantly reduced +1-U proportion, indicating reduced phasing ([Fig 3G](#pgen.1008861.g003){ref-type="fig"}, [S8B Fig](#pgen.1008861.s008){ref-type="supplementary-material"}, [S7 Table](#pgen.1008861.s016){ref-type="supplementary-material"}). However, the more dramatic and statistically significant allelic effect is on ping-pong biogenesis, which is reduced for most TE families by the *D*. *simulans armi* rescue when compared to *D*. *melanogaster* ([Fig 3C and 3D](#pgen.1008861.g003){ref-type="fig"}, [S7C Fig](#pgen.1008861.s007){ref-type="supplementary-material"}, [S5 Table](#pgen.1008861.s014){ref-type="supplementary-material"}). Importantly, this reduction occurs regardless of whether *armi* function enhances or represses ping-pong biogenesis, revealing a global inhibitory effect imposed by *D*. *simulans armi*. Indeed, although the differential abundance of TE and repeat-derived piRNAs between transgenic rescues rarely exceeded two-fold, significantly more TE families were more abundant in the presence of the *D*. *melanogaster armi* rescue compared to the *D*. *simulans armi* rescue (118 out of 131 TE families, Sign-test, *P*-value \< 10^−15^). Therefore, the modest reductions in ping-pong and phasing biogenesis exhibited by the *D*. *simulans armi* allele lead to a similarly modest reduction in the abundance of TE and repeat-derived piRNAs.

Increased off-target effects of *D*. *simulans* alleles suggest increased genomic auto-immunity {#sec006}
-----------------------------------------------------------------------------------------------

While effective negative regulation of TE transcripts is a critical function of piRNA pathway proteins, it is equally important that they avoid off-target effects that interfere with the function of host genes. \[[@pgen.1008861.ref019],[@pgen.1008861.ref021]\]. Aub, Spn-E and Armi are all RNA binding proteins that must specifically interact with piRNAs, piRNA precursors, and target transcripts, while avoiding interactions with cytoplasmic mRNAs. We therefore considered whether off-target effects differ between *D*. *melanogaster* and *D*. *simulans* alleles, predicting that *D*. *simulans* alleles may produce more off-target effects as they are not adapted to avoid interactions with *D*. *melanogaster* transcripts.

To test this prediction, we first identified protein-coding genes that are negatively regulated by piRNA pathway proteins by comparing their expression levels between mutants and transgenic rescues ([S8 Table](#pgen.1008861.s017){ref-type="supplementary-material"}). Protein-coding genes whose expression is significantly reduced in transgenic rescues (\>1.5 fold) are candidates for off-target effects of piRNA-mediated silencing. We observed that for all three proteins, significantly more genes decreased than increased in expression in transgenic rescues compared to mutants ([Fig 4A](#pgen.1008861.g004){ref-type="fig"}), suggesting that piRNA pathway proteins tend to reduce the expression of protein-coding genes. Furthermore, the majority of protein-coding genes that are negatively regulated by *D*. *melanogaster* rescues are also repressed by *D*. *simulans* rescues, suggesting a shared impact on the expression of many protein-coding genes ([Fig 4B and 4C](#pgen.1008861.g004){ref-type="fig"}). Indeed, protein-coding genes that are down-regulated by *aub* alleles from either species are enriched among mRNAs bound by Aub (Pearson\'s Chi-squared test, *P*-value = 0.04) \[[@pgen.1008861.ref045]\].

![Negative regulation of protein-coding genes suggests increased genomic auto-immunity of *D*. *simulans* alleles.\
(A) The number of genes whose expression levels are decreased/increased (\>1.5 fold, blue/red) in the presence of each transgene as compared to the corresponding mutant. Statistical significance was assessed by the binomial test evaluating the probability of the observed proportion of down-regulated genes as compared to up-regulated genes under the null hypothesis that the two probabilities are equal. (B) The number of genes whose expression levels are decreased (\>1.5 fold) in the presence of each transgene as compared to the corresponding mutant. Contingency tables are shown below. Statistical significance was assessed by the Pearson\'s Chi-squared Test of Independence. (C) Overlap of genes whose expression levels are decreased (\>1.5 fold) in the presence of each transgene as compared to the corresponding mutant for *aub* (left Venn diagram), *spn-E* (middle Venn diagram) and *armi* (right Venn diagram). (D) For genes whose expression levels are down-regulated by alleles from either species, the number of those whose transcripts are more abundant in *D*. *melanogaster* rescues than in *D*. *simulans* rescues is in yellow (log2 fold-change between *D*. *mel* and *D*. *sim* \> 0), whereas the reciprocal is in blue. Log2 fold-change values of gene expression are based on one biological replicate for *aub* and three biological replicates for *spn-E* and *armi*, and are obtained from a DESeq analysis for *aub* and a DESeq2 analysis for *spn-E* and *armi* (adjusted *p* \< 0.05 for Fig 4A--4C). (E) For genes whose expression levels are down-regulated by alleles from either species, the number of those whose antisense/sense piRNAs are more abundant in *D*. *melanogaster* rescues than in *D*. *simulans* rescues is in yellow (log2 fold-change between *D*. *mel* and *D*. *sim* \> 0), whereas the reciprocal is in blue. Genes whose piRNA abundance is too low to estimate the differential expression (\< 50 piRNAs on average in at least one genotype) are represented in gray. Genic piRNA abundance is based on two biological replicates for *aub* and three biological replicates for *spn-E* and *armi*, and was normalized to the total number of sequenced miRNAs in the same library. The number of genes corresponding to the blue or yellow part of the bar graph is indicated in Fig 4D and 4E. NS denotes *p* \> 0.05. \* denotes *p* ≤ 0.05. \*\* denotes *p* ≤ 0.01. \*\*\* denotes *p* ≤ 0.001.](pgen.1008861.g004){#pgen.1008861.g004}

Consistent with the auto-immunity hypothesis, we observed expanded negative regulation of protein coding genes by *D*. *simulans* alleles of both *aub* and *armi*. While both *D*. *melanogaster* and *D*. *simulans* alleles tend to decrease expression of host genes, significantly more genes exhibit reduced expression when the *D*. *simulans* transgenic rescue is compared to the mutant (Pearson\'s Chi-squared test, *P*-value = 0.01338 for *aub*; Pearson\'s Chi-squared test, *P*-value = 4.519×10^−7^ for *armi*) ([Fig 4B](#pgen.1008861.g004){ref-type="fig"}). Furthermore, among those protein-coding genes down-regulated by either transgene, there is a systematic bias towards lower expression in the presence of the *D*. *simulans* alleles (One-sample Sign-Test, *P*-value = 0.001195 for *aub*; One-sample Sign-Test, *P*-value = 1.332×10^−15^ for *armi*). However, the majority of these genes are not significantly differentially expressed between transgenic rescues (127 out of 132 genes for *aub*, 481 out of 487 genes for *armi*) ([Fig 4D](#pgen.1008861.g004){ref-type="fig"}, [S9 Table](#pgen.1008861.s018){ref-type="supplementary-material"}), indicating that expanded negative regulation by *D*. *simulans* alleles exhibits only a subtle effect on host gene expression.

Increased off-target effects of *D*. *simulans* alleles could be explained by increased production of antisense genic piRNAs that target host transcripts, or by piRNA-independent interactions between proteins and mRNAs. Recent analyses of off-target interactions between host mRNAs and Piwi (closely related to Aub) or Armi support the latter scenario, suggesting that while the binding of host mRNAs by piRNA proteins reduces mRNA abundance, it does not result from enhanced antisense genic piRNA production \[[@pgen.1008861.ref030],[@pgen.1008861.ref046],[@pgen.1008861.ref047]\]. We therefore compared the abundance of antisense genic piRNAs that target the silencing of sense transcripts between transgenic rescues ([S9 Table](#pgen.1008861.s018){ref-type="supplementary-material"}). Of 132 and 487 protein-coding genes that are negatively regulated by either allele of *aub* and *armi*, only 13 and 50 are meaningfully targeted by antisense piRNAs, respectively (i.e. \>50 antisense piRNAs on average are observed in at least one genotype, [Fig 4E](#pgen.1008861.g004){ref-type="fig"}). Furthermore, no significant bias towards increased antisense piRNA production in the *D*. *simulans* allele was observed for either gene; indeed *D*. *simulans armi* even exhibits decreased, not increased, antisense piRNA abundance when compared to *D*. *melanogaster* (One-sample Sign-Test, *P*-value = 0.09229 for *aub*; One-sample Sign-Test, *P*-value = 2.386×10^−5^ for *armi*) ([Fig 4E](#pgen.1008861.g004){ref-type="fig"}). Finally, *D*. *simulans* transgenic rescues do not exhibit expanded production of genic piRNAs for any of the three proteins ([S9 Fig](#pgen.1008861.s009){ref-type="supplementary-material"}). Therefore, enhanced negative regulation of host mRNAs by *D*. *simulans* Aub and Armi appears to be independent of antisense piRNA production, and may arise through more frequent binding of *D*. *simulans* proteins to *D*. *melanogaster* transcripts.

If *D*. *simulans* Aub and Armi proteins exhibit enhanced binding to *D*. *melanogaster* mRNAs independently of antisense piRNAs, they could introduce them into the piRNA pool by treating them as substrates for piRNA maturation. Consistent with this model, we observed that sense piRNAs derived from genic transcripts that are negatively regulated by either transgene are significantly more likely to be more abundant in the presence of *D*. *simulans* alleles of *aub* and *armi* when compared to *D*. *melanogaster* (One-sample Sign-Test, *P*-value = 6.54×10^−7^ for *aub*; One-sample Sign-Test, *P*-value = 0.0002476 for *armi*). However, as with host mRNAs, these increases in sense piRNA abundance are subtle and predominantly not significant for individual genes (71 out of 72 genes in *aub* comparison, and 236 out of 244 genes in *armi* comparison are not significantly different) ([Fig 4E](#pgen.1008861.g004){ref-type="fig"}, [S9 Table](#pgen.1008861.s018){ref-type="supplementary-material"}). While these modest increases in sense piRNA abundance are consistent with the use of host mRNAs as substrates for piRNA biogenesis, it is also possible that host mRNAs bound by piRNA proteins may be eliminated by the mRNA degradation machinery \[[@pgen.1008861.ref048],[@pgen.1008861.ref049]\].

Discussion {#sec007}
==========

Despite pervasive adaptive evolution and gene duplication among piRNA pathway proteins in both insect and vertebrate lineages \[[@pgen.1008861.ref012]--[@pgen.1008861.ref015],[@pgen.1008861.ref050],[@pgen.1008861.ref051]\], the underlying forces that drive these evolutionary dynamics remain unclear. By performing interspecific complementation on three adaptively evolving piRNA pathway genes, we revealed diverged functions that may have arisen through positive selection. For all three proteins we observed idiosyncratic differences in TE regulation between *D*. *melanogaster* and *D*. *simulans* alleles, which is consistent with genetic conflict between host and parasite. However, we also revealed more extensive off-target effects and reduced efficiency of piRNA maturation associated with *D*. *simulans* alleles of both *aub* and *armi*, suggesting that selection acts to maximize biogenesis function while minimizing friendly fire on host transcripts. Taken together, our results suggest that positive selection acts at multiple molecular and functional interfaces within the piRNA pathway.

The simplest explanation for the adaptive evolution of piRNA proteins is that selection acts to maximize host control of TE transposition. At face value, TEs that are differentially expressed between transgenes from the two species seem to support this model ([Fig 2A](#pgen.1008861.g002){ref-type="fig"}). However, all 5 of these TE families were more robustly silenced by the heterospecific *D*. *simulans* proteins. This suggests that rather than conspecific piRNA proteins being well-adapted to silence their genomic TEs, active genomic TEs may be well-adapted to evade silencing by their host regulators. Indeed the *tirant* element, which is more robustly regulated by *D*. *simulans* alleles of both *armi* and *spn-E*, is unusually active in *D*. *melanogaster* but is being actively lost from *D*. *simulans* \[[@pgen.1008861.ref052]--[@pgen.1008861.ref054]\]. We propose that the differential evolutionary dynamics of *tirant* in these two lineages may in part reflect the differences in host-control that we have uncovered.

Genomic auto-immunity was recently proposed as an additional target of positive selection among piRNA proteins \[[@pgen.1008861.ref019]\]. The deliberate non-specificity of piRNA pathway proteins that allows them to target any sequence represented among piRNAs for silencing presents a huge liability for host-gene regulation: how can piRNA proteins avoid deleterious interactions with host transcripts? Furthermore, RNA-immunoprecipitation (RIP) and cross-linking immunoprecipitation (CLIP) of Piwi suggest that piRNA proteins may also negatively regulate host mRNAs by binding them directly in a piRNA-independent manner \[[@pgen.1008861.ref046],[@pgen.1008861.ref047]\]. Similar observations have been made with Armi protein, with the ATP-ase domain being required to disassociate Armi from host mRNAs in the cytoplasm \[[@pgen.1008861.ref030]\]. We observed that *D*. *simulans armi* and *aub* alleles are characterized by expanded negative regulation of host genes ([Fig 4A--4C](#pgen.1008861.g004){ref-type="fig"}), which is accompanied by reduced efficiency of TE-derived piRNA production ([Fig 3](#pgen.1008861.g003){ref-type="fig"}). Importantly, this observation is not consistent with a subtle difference in protein abundance between transgenic rescues, since this would reduce both piRNA biogenesis and off-target effects. Rather our observations suggest that *D*. *simulans* alleles bind more frequently to host mRNAs ([Fig 4](#pgen.1008861.g004){ref-type="fig"}), thereby reducing host-gene expression and depleting the pool of protein available to enact piRNA maturation. Nevertheless, we cannot discount an equally intriguing alternative explanation: that *D*. *simulans* alleles have decreased affinity for interacting protein partners that mediate piRNA biogenesis, which liberates them to bind more frequently to host mRNAs. Future comparisons of molecular interactions involving *D*. *melanogaster* and *D*. *simulans* proteins could differentiate between these alternatives.

Our observations considerably expand our understanding of the enigmatic forces that drive adaptive evolution across the piRNA pathway. The three proteins we studied here, which are cytoplasmic factors involved in piRNA maturation and post-transcriptional silencing, provide an informative contrast to similar studies of three adaptively evolving nuclear transcriptional silencing factors: Rhino, Deadlock and Cutoff \[[@pgen.1008861.ref020],[@pgen.1008861.ref022],[@pgen.1008861.ref055]\]. In comparison to the modest functional differences we observed between *D*. *melanogaster* and *D*. *simulans* alleles, nuclear factors are characterized by dramatic interspecific divergence, with *D*. *simulans* alleles behaving similarly to loss of function or dominant negative mutations \[[@pgen.1008861.ref020],[@pgen.1008861.ref022],[@pgen.1008861.ref055]\]. Furthermore, adaptive evolution among transcriptional silencers has resulted in interspecific incompatibilities between interacting proteins, as opposed to the divergence in protein-RNA interactions that our data suggest. These observations logically reflect differences in the molecular functions of the two classes of proteins, with transcriptional regulation relying on suites of proteins that modify chromatin or regulate RNA-polymerase, while piRNA maturation and post-transcriptional silencing relies more on interactions between proteins and RNA.

Interestingly, a recent meta-analysis of piRNA protein evolution in insects revealed that while positive selection is pervasive throughout the piRNA pathway, signatures of adaptive evolution are significantly stronger among nuclear transcriptional regulators, as compared to the cytoplasmic factors we studied here \[[@pgen.1008861.ref014]\]. Thus, our functional analysis recapitulates an evolutionary signature in sequence data. Why might nuclear transcriptional regulators diverge more rapidly or dramatically than their cytoplasmic counterparts? Enhanced positive selection on nuclear factors may reflect their greater potential to fully suppress the expression of host genes through disrupted chromatin state, as opposed to depleting host transcripts through non-productive binding \[[@pgen.1008861.ref019]\]. We therefore propose that off-target effects may play an under-appreciated role in the evolution of both nuclear and cytoplasmic piRNA proteins, with the strength and consequences of positive selection depending on the mechanisms of---and costs to---host gene regulation.

Materials and methods {#sec008}
=====================

Fly strains and crosses {#sec009}
-----------------------

All *Drosophila* strains were reared at room temperature on standard cornmeal media.

For the studies of *aubergine* (*aub*), the following *D*. *melanogaster* strains were used: *w; aub*^*N11*^ *bw*^*1*^*/CyO*, *y w; aub*^*HN*^ *bw*^*1*^*/CyO*, *y w; aub*^*HN*^ *bw*^*1*^*/CyO; ΦP{D*. *melanogaster aub}*, and *y w; aub*^*HN*^ *bw*^*1*^*/CyO; ΦP{D*. *simulans aub}*. *w; aub*^*N11*^ *bw*^*1*^*/CyO*, was a gift from Paul MacDonald. *y w; aub*^*HN*^ *bw*^*1*^*/CyO* was obtained by extracting *y w* into *aub*^*HN*^ *bw*^*1*^*/CyO* (Bloomington *Drosophila* Stock Center \#8517). *y w; aub*^*HN*^ *bw*^*1*^*/CyO; ΦP{D*. *melanogaster aub}* and *y w; aub*^*HN*^ *bw*^*1*^*/CyO; ΦP{D*. *simulans aub}*, originally generated in Kelleher et al \[[@pgen.1008861.ref031]\], were backcrossed for 6 generations in *y w; aub*^*HN*^ *bw*^*1*^*/CyO* to minimize background effects that could lead to differences between transgenic stocks that are unrelated to the transgenes.

For the studies of *spindle-E* (*spn-E*), the following *D*. *melanogaster* strains were used: *y w; spn-E*^*1*^*/TM6*, *y w; spn-E*^*hls-03987*^*/TM6*, *y w; spn-E*^*hls-03987*^*/TM6; ΦP{D*. *melanogaster spn-E}*, and *y w; spn-E*^*hls-03987*^*/TM6; ΦP{D*. *simulans spn-E}*. *y w; spn-E*^*1*^*/TM6* and *y w; spn-E*^*hls-03987*^*/TM6* were obtained by crossing *spn-E*^*1*^*/TM3* and *spn-E*^*hls-03987*^*/TM3* (gifts from Celeste Berg) to *y w; TM3/TM6*. To generate *y w; spn-E*^*hls-03987*^*/TM6; ΦP{D*. *melanogaster spn-E}* and *y w; spn-E*^*hls-03987*^*/TM6; ΦP{D*. *simulans spn-E}*, *w*^*1118*^*; ΦP{D*. *melanogaster spn-E}* and *w*^*1118*^*; ΦP{D*. *simulans spn-E}* were first crossed to *y w; TM3/TM6*. *+/TM6; ΦP{D*. *melanogaster spn-E}/+* and *+/TM6; ΦP{D*. *simulans spn-E}/+* offspring were then crossed to *y w; spn-E*^*hls-03987*^*/TM3*. Finally, *y w; spn-E*^*hls-03987*^*/TM6; ΦP{D*. *melanogaster spn-E}/+* and *y w; spn-E*^*hls-03987*^*/TM6; ΦP{D*. *simulans spn-E}/+* offspring were backcrossed into *y w; spn-E*^*hls-03987*^*/TM6* for 6 generations, and subsequently homozygosed for the transgene, to minimize background effects.

For the studies of *armitage* (*armi*), the following *D*. *melanogaster* strains were used: *y w; armi*^*1*^*/TM6*, *w; armi*^*72*.*1*^*/TM6*, *w; armi*^*72*.*1*^*/TM6; ΦP{D*. *melanogaster armi}*, and *w; armi*^*72*.*1*^*/TM6*; *ΦP{D*. *simulans armi}*. *y w; armi*^*1*^*/TM6* was obtained by crossing *y w; armi*^*1*^*/TM3* (Bloomington *Drosophila* Stock Center \#8513) to *y w; TM3/TM6*. *w; armi*^*72*.*1*^*/TM6* was obtained from Bloomington *Drosophila* Stock Center (\#8544). To generate *w; armi*^*72*.*1*^*/TM6; ΦP{D*. *melanogaster armi}* and *w; armi*^*72*.*1*^*/TM6*; *ΦP{D*. *simulans armi}*, *w*^*1118*^*; ΦP{D*. *melanogaster armi}* and *w*^*1118*^*; ΦP{D*. *simulans armi}* were first crossed to *y w; TM3/TM6*. *+/TM3; ΦP{D*. *melanogaster armi}/+* and *+/TM3; ΦP{D*. *simulans armi}/+* offspring were then crossed to *w; armi*^*72*.*1*^*/TM6*. Finally, *w; armi*^*72*.*1*^*/TM3; ΦP{D*. *melanogaster armi}/+* and *w; armi*^*72*.*1*^*/TM3*; *ΦP{D*. *simulans armi}/+* were backcrossed into *w; armi*^*72*.*1*^*/TM6* for 6 generations, and subsequently homozygosed for the transgene, to minimize background effects.

Experimental genotypes were obtained from the following crosses. For studies of *aub*, virgin females *w; aub*^*N11*^ *bw*^*1*^*/CyO* were crossed to (1) *y w; aub*^*HN*^ *bw*^*1*^*/CyO*, (2) *y w; aub*^*HN*^ *bw*^*1*^*/CyO; ΦP{D*. *melanogaster aub}* or (3) *y w; aub*^*HN*^ *bw*^*1*^*/CyO; ΦP{D*. *simulans aub}* males. For studies of *spn-E*, virgin females *y w; spn-E*^*1*^*/TM6* were crossed to (1) *y w; spn-E*^*hls-03987*^*/TM6*, (2) *y w; spn-E*^*hls-03987*^*/TM6; ΦP{D*. *melanogaster spn-E}* or (3) *y w; spn-E*^*hls-03987*^*/TM6; ΦP{D*. *simulans spn-E}* males. For studies of *armi*, virgin females *y w; armi*^*1*^*/TM6* were crossed to (1) *w; armi*^*72*.*1*^*/TM6*, (2) *w; armi*^*72*.*1*^*/TM6; ΦP{D*. *melanogaster armi}* or (3) *w; armi*^*72*.*1*^*/TM6*; *ΦP{D*. *simulans armi}* males. Crosses were maintained at 25°C on standard cornmeal media.

Generation of transgenic lines {#sec010}
------------------------------

To introduce *D*. *melanogaster* and *D*. *simulans* alleles into *D*. *melanogaster*, we used *Φ*C31 integrase-mediated transgenesis system \[[@pgen.1008861.ref041]\], which allows for site-specific integration. To generate transgenes, the gene and flanking regulatory regions of *spn-E* (\~9.7Kb, *D*. *melanogaster* Release 6, 3R:15835349..15845065; *D*. *simulans* Release 2, 3R:9575537..9585081) \[[@pgen.1008861.ref056],[@pgen.1008861.ref057]\] and *armi* (\~6Kb, *D*. *melanogaster* Release 6, 3L:3460305..3466368; *D*. *simulans* Release 2, 3L:3357002..3363099) \[[@pgen.1008861.ref056],[@pgen.1008861.ref057]\] were PCR-amplified by using corresponding primers (below) and iProof high-fidelity taq DNA polymerase (Bio-Rad).

1.  *D*.*mel/D*.*sim-spn-E* forward primer: ATTGAACGCCGTCTATGCCAAGC

2.  *D*.*mel/D*.*sim-spn-E* reverse primer: ACTGTTCGCCATTGCCACAGATTG

3.  *D*.*mel/D*.*sim-armi* forward primer: CACCGCTGAAAGATACGCACACG

4.  *D*.*mel-armi* reverse primer: GCTAGCCTGCGCTTGGGAGTGTTACCATTCG

5.  *D*.*sim-armi* reverse primer: GCTAGCCTGACCTCGGGAGTGTTACCACTTC

The PCR products were cloned into pCR-Blunt-II-Topo according to manufacturer instructions (Invitrogen). Mutation-free clones were verified by sequencing.

attB-containing constructs used for site-specific integration were generated by subcloning the NotI/BamHI fragment of each *spn-E* TOPO plasmid, and the NotI/NheI fragment of each *armi* TOPO plasmid into NotI/BamHI and NotI/XbaI-linearized pCasper4/attB \[[@pgen.1008861.ref058]\], respectively. *spn-E* and *armi* transgenic constructs were introduced into *D*. *melanogaster* at the P{CaryP}attP40 site, and site-specific integration of transgenes was confirmed by PCR \[[@pgen.1008861.ref059]\]. The resulting transgenes were made homozygous in *D*. *melanogaster w*^*1118*^. Transgenes are indicated as *Φ*P{} in genotypes.

Female fertility {#sec011}
----------------

25--35 individual virgin females of each experimental genotype were crossed to two *y w* males on standard cornmeal media at 25°C. Fresh media and new males were provided every 5 days. The number of progeny from each 5-day period was quantified.

Small RNA-seq {#sec012}
-------------

3-6-day old female ovaries were dissected from each experimental genotype and placed directly in Trizol reagent (Invitrogen), and homogenized. For *aub* genotypes, Illumina small RNA libraries were prepared by Fasteris according to a proprietary protocol that depletes for 2S-RNA. Because the two biological replicates were prepared at different time points (5/13 and 7/13), they were analyzed separately. Small RNA libraries for *spn-E* and *armi* genotypes were prepared as described in \[[@pgen.1008861.ref060]\]. In brief, total RNAs were extracted according to the manufacturer's instructions, and size fractionated on a 12% polyacrylamide/urea gel to select for 18--30 nt small RNAs. Small RNAs were treated with 2S Block oligo (5'-TAC AAC CCT CAA CCA TAT GTA GTC CAA GCA/3SpC3/-3'), and were subsequently ligated to 3' and 5' adaptors, reverse transcribed and PCR amplified using NEBNext Multiplex Small RNA Library Prep Set for Illumina. Small RNA libraries were further purified from a 2% agarose gel and sequenced on a Illumina NextSeq 500 at the University of Houston Seq-N-Edit Core.

RNA-seq {#sec013}
-------

RNA-seq libraries for the studies of *aub* were generated by Weill Cornell Epigenomics Core according to the protocol of \[[@pgen.1008861.ref061]\]. Briefly, total RNA was extracted from the same ovaries as above, and mRNAs were isolated using poly-T Dynabeads (Invitrogen) according to the manufacturer's instructions. Isolated mRNAs were further fragmented using fragmentation buffer (Ambion), ethanol precipitated, and reverse transcribed using Superscript II (Invitrogen) and random hexamer primers. Second-strand synthesis was performed using DNA polymerase I (Promega). cDNA was purified on a MinElute column (Qiagen), repaired with End-IT DNA repair kit (Epicentre), A-tailed with Klenow enzyme (New England Biolabs), and ligated to Illumina adaptors. Ligated cDNA was gel purified with the MinElute gel purification kit (Qiagen), PCR amplified, and gel purified again to make libraries.

RNA-seq libraries for the studies of *spn-E* and *armi* were prepared by using TruSeq Stranded Total RNA Library Preparation Kit for Illumina. 50 bp reads from each library were sequenced on a HiSeq 2000 (Aub and Spn-E) and a HiSeq 2500 (Armi) by the Weill-Cornell Epigenomics Core. RNA-seq and small RNA-seq data sets are deposited under PRJNA494103.

Bioinformatic analysis of small RNA-seq libraries {#sec014}
-------------------------------------------------

3' Illumina adaptors were removed from sequencing reads by Cutadapt \[[@pgen.1008861.ref062]\]. Sequence alignments were made by Bowtie \[[@pgen.1008861.ref063]\]. Contaminating ribosomal RNAs were identified and removed by mapping sequencing reads to annotated ribosomal RNAs from flybase \[[@pgen.1008861.ref064]\]. TE-derived piRNAs and genic piRNAs were identified by aligning sequencing reads ranging from 23--30 nucleotides (nt) to Repbase \[[@pgen.1008861.ref065]\] or protein-coding gene reference sequence from Flybase \[[@pgen.1008861.ref064]\], respectively, allowing for up to 2 mismatches. The number of reads mapped to each TE family or gene were counted using a Linux shell script. Redundant TE families in Repbase were identified by checking sequence identity (those consensus sequences that were \>90% identical across \>90% of their length were categorized as the same TE family), and reads mapped to multiple redundant TE families were counted only once. Reads mapped to multiple non-redundant TE families were discarded. To identify miRNAs sequencing reads ranging from 18--22 nt were aligned to a miRNA reference sequence from Flybase \[[@pgen.1008861.ref064]\]. TE families or genes with low read count (\< 50 on average) in every genotype library were discarded. piRNA counts for each TE family or gene were normalized to the total number of sequenced miRNAs from each library. Normalized values were used for comparisons of the abundance of piRNAs between libraries.

Bioinformatic analysis of RNA-seq libraries {#sec015}
-------------------------------------------

Removal of ribosomal RNAs, and identification of TE-derived reads was performed as for small RNA libraries (above) except that 3 mismatches were permitted between sequencing reads and TE consensus sequences. Non TE-derived reads were aligned to flybase annotated transcripts in the *D*. *melanogaster* reference genome (*D*. *melanogaster* Release 6) \[[@pgen.1008861.ref056],[@pgen.1008861.ref064]\] by TopHat \[[@pgen.1008861.ref066]\], requiring unique mapping. The number of reads from each protein-coding gene were counted using HTseq-count \[[@pgen.1008861.ref067]\]. TE families or genes with low read count (\< 50 on average) in every genotype were discarded. Differential expression was estimated concurrently for TEs and protein-coding genes by DESeq for *aub* \[[@pgen.1008861.ref068]\] and DESeq2 for *spn-E* and *armi* \[[@pgen.1008861.ref043]\]. TEs or protein-coding genes were considered differentially expressed if they exhibited an adjusted *P*-value \< 0.05 and a fold-change \> 2 for TEs and \> 1.5 for protein-coding genes.

Ping-pong fraction {#sec016}
------------------

Ping-pong fraction was calculated as described in \[[@pgen.1008861.ref069]\]. In brief, small RNA sequencing reads ranging from 23--30 nt were aligned to TE consensus sequences from Repbase \[[@pgen.1008861.ref065]\], and redundant TE families in Repbase were identified as described above. For each piRNA, the proportion of overlapping antisense binding partners whose 5' end occurs on the 10th nucleotide was determined. This fraction was subsequently summed across all piRNAs from a given TE family, while incorporating the difference in sampling frequency between individual piRNAs. Finally, this sum was divided by the total number of piRNAs aligned to the TE family of interest. For multi-mappers, reads were apportioned by the number of times they can be aligned to the reference.

Phasing analysis {#sec017}
----------------

Small RNA sequencing reads ranging from 23--30 nt were aligned to the Repbase \[[@pgen.1008861.ref065]\], and redundant TE families in Repbase were identified as described above. To calculate the d1 proportion \[[@pgen.1008861.ref034]\], the number of piRNAs whose 5' end was 1--22 nt downstream piRNA was determined for every TE-derived piRNA. The fraction of distances corresponding to 1 nt was then calculated. To calculate the +1-U proportion \[[@pgen.1008861.ref034]\], the nucleotide after the 3' end of each piRNA was determined based on alignment to the Repbase \[[@pgen.1008861.ref065]\]. The frequency of each nucleotide at the +1 position was subsequently summed across all piRNAs from a given TE family, and the proportion of uridine was calculated. For both analyses, multiply-mapping reads were apportioned by the number of times they aligned to the reference.

Supporting information {#sec018}
======================

###### *Drosophila melanogaster* genotypes and crossing scheme.

(TIF)

###### 

Click here for additional data file.

###### Similar expression level of *aub*, *spn-E* and *armi* transgenes, as well as germline and soma specific genes between *D*. *melanogaster* transgenic rescue and *D*. *simulans* transgenic rescue.

Fold-change of expression level of *aub*, *spn-E*, *armi*, germline-specific genes and soma-specific genes between *D*. *melanogaster* transgenic rescue and *D*. *simulans* transgenic rescue are shown. Fold-change values are based on one biological replicate for *aub* and three biological replicates for *spn-E* and *armi*, and were obtained from a DESeq analysis for *aub* and a DESeq2 analysis for *spn-E* and *armi*. \*\* denotes *p* ≤ 0.01. NS if not labeled.

(TIF)

###### 

Click here for additional data file.

###### Size distribution and composition of the small RNA pool for each genotype.

(TIF)

###### 

Click here for additional data file.

###### *Drosophila melanogaster* transgenes exhibit similar profiles of piRNA biogenesis to heterozygotes.

*Drosophila melanogaster* transgenes and heterozygotes are compared to trans-heterozygous mutants with respect to transcript abundance (A), TE-derived piRNA abundance (B), ping-pong and phasing biogenesis (C). RNA-seq data comparing *aub* heterozygotes and trans-heterozygous mutants is from \[[@pgen.1008861.ref070]\]. Transcript abundance was normalized to the total number of mapped reads of that library. The small RNA-seq data comparing heterozygotes and mutants for *aub*, *spn-E* and *armi* are from \[[@pgen.1008861.ref071]\]. TE-derived piRNA abundance was normalized to the total number of sequenced miRNAs in the same library. Statistical significance was assessed by the Wilcoxon signed-rank test. For *aub*, two biological replicates of each genotype generated at different times are shown separately. For *spn-E* and *armi*, averages of three biological replicates of each genotype generated at the same time are shown. NS denotes *p* \> 0.05. \*, \*\*, and \*\*\* denote *p* ≤ 0.05, *p* ≤ 0.01, *p* ≤ 0.001, respectively.

(TIF)

###### 

Click here for additional data file.

###### Decoupling between changes in TE transcript abundance and changes in TE-derived piRNA abundance.

Log2 fold-change TE transcript abundance and TE-derived sense/antisense piRNA abundance between two transgenic rescues for the TE families whose TE transcript abundance is substantively different (\> 2 fold) between two rescues from [Fig 2A](#pgen.1008861.g002){ref-type="fig"}. Red dashed lines indicate the 2 fold-change threshold.

(TIF)

###### 

Click here for additional data file.

###### Minimal differences in sense piRNA production between alleles.

(TIF)

###### 

Click here for additional data file.

###### Ping-pong fraction heat map for each protein studied.

\(A\) *aub*, (B) *spn-E* and (C) *armi*. Among (C), 88 and 42 TE families whose ping-pong fractions are decreased (below red line) or increased (above red line), respectively, in *armi* mutant as compared to those in *D*. *melanogaster* transgenic rescue are shown.

(TIF)

###### 

Click here for additional data file.

###### 

Observed peaks of 1nt distance (A) and +1-U bias (B) among each genotype for each protein studied.

(TIF)

###### 

Click here for additional data file.

###### Auto-immunity analysis for the genic piRNA profile.

The number of genes whose corresponding total (A) / anti-sense (B) / sense (C) piRNA abundance is increased (\>1.5 fold) in the presence of each transgene as compared to the mutant. Contingency tables are shown below. Log2 fold-change values were based on two biological replicates for *aub* and three biological replicates for *spn-E* and *armi*, and were obtained from a DESeq2 analysis (adjusted *p* \< 0.05). Statistical significance was assessed by the Pearson\'s Chi-squared test. NS denotes *p* \> 0.05. \* denotes *p* ≤ 0.05.

(TIF)

###### 

Click here for additional data file.

###### Offspring count from the female fertility test.

(XLS)

###### 

Click here for additional data file.

###### RNA-seq and small RNA-seq library statistics.

(XLS)

###### 

Click here for additional data file.

###### Normalized abundance and differential expression of TE transcripts.

(XLS)

###### 

Click here for additional data file.

###### Normalized abundance and differential expression of TE-derived piRNAs.

(XLS)

###### 

Click here for additional data file.

###### piRNA ping-pong biogenesis signature for TE-derived piRNAs.

(XLS)

###### 

Click here for additional data file.

###### piRNA phasing biogenesis signature (d1 proportion) for TE-derived piRNAs.

(XLS)

###### 

Click here for additional data file.

###### piRNA phasing biogenesis signature (+1-U proportion) for TE-derived piRNAs.

(XLS)

###### 

Click here for additional data file.

###### Protein-coding genes that are differentially regulated by transgenes as compared to the mutant.

(XLS)

###### 

Click here for additional data file.

###### Log2 fold-change of transcript/piRNA abundance between *D*. *mel rescue* and *D*. *sim rescue*, for protein-coding genes whose expression levels are down-regulated by alleles from either *D*. *melanogaster* or *D*. *simulans*.

(XLS)

###### 

Click here for additional data file.
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9 Sep 2019

Dear Dr Kelleher,

Thanks very much for submitting your manuscript to PloS Genetics.  

I\'ve carefully read the paper and reviews. As you can see below, the reviewers were intrigued by your findings, but would like to see a more thorough analysis of certain points. In general, the reviewers were thorough, and I think careful attention to their comments will improve the paper, particularly where more clarification or analyses are requested to support its main claims.   

In particular, the reviewers suggested several analyses that might provide insight into the difference between the Dsim and Dmel rescue alleles. These include some clarification of analyses in the paper, as well as some sensible suggestions for additional analyses, e.g., an analysis of potential functional divergence due to protein or silent site evolution (which may either provide an alternative explanation or better supports the model in the discussion), and analysis of transposable elements with abundance differences between the species. 

The authors should also provide a fuller justification of their controls for this finding (which is Dmel rescue rather than Dmel wild-type).

The reviewers were particularly curious about insight into the autoimmunity effect of the Dsim rescue allele.  In addition to the reviewers\' comments, I had wondered if there were an differences in the characteristics of the genic piRNAs between the mel-armi and sim-armi rescue strains, despite the similar abundances?

Please also pay attention to reviewer 3\'s request for additional data in the supplement.

Finally, a few minor changes might also make the manuscript easier to understand, particularly the changes to figures suggested by reviewers 3 and 4. In addition to those, I had a few suggestions of my own. 1-The supplementary figure 1 showing which strains are compared would be better as a panel for figure 1 in the main text; otherwise, it\'s difficult to quickly grasp what comparisons are being made. (Incidentally, this figure\'s legend is also a little confusing.); 2-In the materials and methods, it would be better to replace the long lists of strains with a table. 

\[GPC Note - At least one reviewer noted that \"spreadsheets for numerical data underlying graphs, and summary statistics of sRNA and RNA-seq data were not provided\". Please note that under PLOS Genetics\' data access policy this must be provided - please be sure to attend to this while preparing your revised manuscirpt.\]

(Below is the standard boilerplate from the journal; I look forward to seeing a revised version of this manuscript, should you choose to resubmit.)

Thank you very much for submitting your Research Article entitled \'Divergence of piRNA pathway proteins affects piRNA biogenesis and off-target effects, but not TE transcripts, revealing a hidden robustness to piRNA silencing\' to PLOS Genetics. Your manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important problem, but raised some substantial concerns about the current manuscript. Based on the reviews, we will not be able to accept this version of the manuscript, but we would be willing to review again a much-revised version. We cannot, of course, promise publication at that time.

Should you decide to revise the manuscript for further consideration here, your revisions should address the specific points made by each reviewer. We will also require a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

If you decide to revise the manuscript for further consideration at PLOS Genetics, please aim to resubmit within the next 60 days, unless it will take extra time to address the concerns of the reviewers, in which case we would appreciate an expected resubmission date by email to <plosgenetics@plos.org>.

If present, accompanying reviewer attachments are included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our [Submission Checklist](http://journals.plos.org/plosgenetics/s/submit-now#loc-submission-checklist).

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see our [guidelines](http://journals.plos.org/plosgenetics/s/submission-guidelines#loc-materials-and-methods).

Please be aware that our [data availability policy](http://journals.plos.org/plosgenetics/s/data-availability) requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as \"data not shown\" or \"unpublished results\" in manuscripts. All points should be backed up by data provided with the submission.

While revising your submission, please upload your figure files to the [Preflight Analysis and Conversion Engine](http://pace.apexcovantage.com/) (PACE) digital diagnostic tool.  PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>.

PLOS has incorporated [Similarity Check](http://www.crossref.org/crosscheck.html), powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, use the link below and \'Revise Submission\' in the \'Submissions Needing Revision\' folder.

\[LINK\]

We are sorry that we cannot be more positive about your manuscript at this stage. Please do not hesitate to contact us if you have any concerns or questions.

Yours sincerely,

Andrea Betancourt

Guest Editor

PLOS Genetics

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

Reviewer\'s Responses to Questions

**Comments to the Authors:**

**Please note here if the review is uploaded as an attachment.**

Reviewer \#1: The fast evolution of piRNA pathway genes has been widely observed, but the underlying evolutionary mechanism has yet to be elucidated. In this study, authors used interspecific (D. melanogaster vs D. simulans) complementation tests of three fast-evolving piRNA pathway genes to investigate this question. While the authors found a significant difference in piRNA biogenesis between mutants with D. melanogaster vs D. simulans transgenes, they found little difference in terms of the TE transcripts. In addition, the authors found that there are more piRNAoff-target effects on host genes in mutants with D. simulans transgene than those with D. melanogaster transgene. Authors concluded that the main driving force for the fast evolution of piRNA pathway genes might come from piRNA production, instead of abundance, and selection for minimizing the piRNA off-target effects on host genes.

This study addresses an important question and could be of wide interests. However, there are some potential technical caveats, and additional analysis/clarifications may be needed to support authors' conclusions fully. I listed my specific comments below.

1\. Potential dosage effect of Aub, Spn-E, and Armi

According to methods and Figure S1, there is only a copy of the transgene in a null mutant background, which is usually used for rescue experiment. However, many piRNA pathway proteins work in concert, and I am wondering whether there could be dosage imbalance that would influence the biogenesis of piRNAs/TE suppression.

2\. What is the appropriate baseline?

All the phenotypes assayed (female fertility, piRNA biogenesis, and TE transcripts) are compared to D. mel-rescue. However, it may be necessary also to show that D. mel-rescue has similar phenotypes as those of wildtype/background strains, demonstrating that the D. mel transgene indeed rescue. This issue may be especially important given issues raised in (1). It is possible that single-copy D. mel and D. sim rescues both deviate from the wildtype and this results in little difference observed between D. mel and D. sim rescues.

3\. TE families with large divergence in abundance

Although the authors did not find large global differences in TE transcripts between D. mel and D. sim rescues, there are still some families with different transcripts abundance between the two. I am wondering whether these are families that show the largest abundance difference between the two species. It could also be informative to analyze the divergence in piRNA biogenesis with respect to TE copy number difference between the two species.

4\. Off-target effects of piRNAs on host genes

What authors observed (fewer protein-coding genes with increased piRNA abundance in D. sim rescue than D. mel rescue) seems to contradict with their findings and interpretations (D. sim rescue leads to more off-target). More explanations/further investigations may be needed. Also, the authors suggest that this phenomenon is similar to what is observed for TEs -- no correlation between piRNA biogenesis and expression level. However, an analogy may not be directly drawn here. TE transcripts are also involved in the generation of piRNA biogenesis, while host gene transcripts are not. The underlying mechanisms for the observed phenomena could be very different between TEs and host genes.

5\. While I agree with the authors that their finding suggests a threshold effect of piRNA biogenesis (a very important finding!), it is still unclear why piRNA biogenesis may evolve adaptively. Horizontally transferred new TE families/escaped TE families may be one, as proposed by authors, but how the host machinery respond specifically to these families is still unclear. It would be helpful if the authors could further elaborate on this.

Minor comments:

1\. Figure 2C -- where are these 92/43 TE families in Figure 1? Does this categorization correlate with piRNA abundance?

2\. I am a bit confused by Figure 2G, Aub panel. Why the two replicates show different trends (and they are both significant!)?

3\. It would help the readers if authors could include a bit more descriptions of piRNA biogenesis through phasing mechanisms.

4\. 2x2 tables may be more informative than Figure 5A. (As the Y-axis is not labeled and only described in the figure legend).

5\. Figure S2B does not provide enough support that the two transgenes have similar expression level -- formal statistical tests are needed. It is also unclear which transgene was chosen as the baseline for calculating fold change (Y-axis).

Reviewer \#2: Summary

The authors aim to address the causes and consequences of positive selection on three piRNA pathway genes in Drosophila by creating transgenic rescue lines with D. melanogaster and simulans alleles. The manuscript is well-written and the experiment is an important one, and the results should be of great interest to those studying piRNAs in any species, irrespective of the outcome. Somewhat surprisingly, it appears rescuing D. melanogaster piRNA mutants with D. simulans alleles almost fully restores piRNA pathway function, with seemingly only slight differences in biogenesis and no differences in TE transcript abundance. The authors also find a difference in potential off-target effects -- if true, a huge discovery, although more needs to be done to relate this to the other observed phenotypes, as well as confirmatory experiments that Dmel and Dsim proteins are at comparable levels.

Major comments

Overall, more needs to be done to better connect the observed phenotypes and create a clear picture of what the authors propose is happening. This should include both additional analysis (most of which should be able to be mined from available data) and writing, which are outlined separately below.

Analysis/Experiments:

It seems crucial that more should be done to confirm the experiment has worked as expected. For example, are there codon-bias or intron structure differences between melanogaster and simulans that could affect translation? While the authors show similar transcript levels, I think it is imperative that these Dsim and Dmel genes be shown to be translated at similar levels. Even small translation differences in theory could lead to the slightly impaired biogenesis phenotypes observed. Also, figure S2B could use positive controls.

The data presented supporting an autoimmune effect is relatively narrow in scope. Fleshing out this analysis to give a more global picture of what is happening to protein-coding genes during transgene rescue would help readers visualize exactly what is happening. For example, I am also interested in the number of genes that are upregulated by both transgene rescue -- if similar numbers to those downregulated, then this may seem more like noisy RNA-Seq data or broader transcriptional dysregulation. If significantly more genes are downregulated upon rescue than upregulated, this would further support the autoimmunity hypothesis. Second, it seems Figure 5 and Figure S6 should be combined into one analysis addressing the question: Does increased off-target effects lead to any meaningful differences in protein-coding gene expression? The authors show that the number of downregulated genes are more than expected (although I cannot find how "Expected" is calculated) and that the number of piRNA producing protein coding genes is more than expected in Dsim rescue, but these figures don't seem meaningful if there is no overlap. I would also be interested to see how variable piRNA production from CDS is across replicates (for example, does gene X consistently produce more piRNAs upon Dsim rescue, or is a random draw of genes with higher piRNAs from each replicate).

Explanation: A couple of explanations could be provided to better connect the data, and frame it in what is already known or hypothesized. For example, the introduction (starting at P4L20) sets up competing hypotheses for what drives adaptation in piRNA pathway genes. It seems these options should be re-weighed in turn in the discussion. What scenarios is this data consistent with? Yes, various causes of positive selection but also e.g. differences in constraint between species, allowing divergence of neutral variation in Dsim that is functional in Dmel.

Additionally, it is not clear how the authors believe genomic autoimmunity is occurring, and whether it is related to the decreased piRNA biogenesis. It would help readers to either explicitly say that these phenotypes have independent or correlated causes, and to integrate autoimmunity into the Figure 6 summary.

Minor comments

It seems discussing piRNA clusters and their protection would help general interest readers -- without this knowledge the conundrum of why piRNA pathway genes are evolving adaptively is less apparent.

Why no ping-pong peak graphs?

It would help general interest readers to include Spn-E in all of the figures where appropriate, and especially in the summary Figure 6.

On P9L19-20, a reference to Figure 2B should be included alongside 2F and G.

I had a very difficult time interpreting Figure 4B, perhaps explain it more thoroughly in the sentence starting on P13L18 "This counterintuitive positive...", for example something along the lines of "notice how the colors relate in X way with the relationship between LFCs"

It is not clear how expected numbers of autoimmune targets (Figure 5, S6) were calculated, this should be outlined. Also, is the observed significantly different from the expected? I only see a test done for comparing the two observed values, in which case, what are the expected values for?

Discussion P20L9: Typo in melanogaster

Reviewer \#3: Please find the review document (Wang_et_al2019_review.docx) attached.

Reviewer \#4: Overall, the conclusions of this paper are well supported. However, it would be worth outlining some caveats to these interpretations. In addition, in parts, the presentation of the data could be more clear. In places, the impact of the results is somewhat hidden in the visuals.

1\. Could the authors provide an alignment of the protein sequences of the sim and mel alleles? The authors may want to relegate this to the supplemental, but unless these alignments are unwieldy (hopefully they can be presented in a way they are not), I would recommend they put these alignments in the first figure. Without this, the reader is left wondering what kind of divergence there is between the sim and mel protein sequences.

1\. One of the main results is that the sim-armi allele leads to a universal reduction of piRNA abundance against TEs. Since this is normalized against total sequence reads, what small RNA class is increased in their place? In the methods, it is stated that TE-piRNA counts were normalized to miRNA. It would be worth reminding the reader that this class was increased as a proportion of total small RNA reads.

2\. I feel the scatter plot buries the observation of reduced piRNA amounts. Can a miRNA-normalized size histogram of piRNAs mapping to TEs be provided for each of the alleles? That way, the reader can see the whole distribution presumably downshifted for the sim variants - especially for armi. This would hide some of the TE level variation for sim spnE, but would be a helpful view of total piRNA amounts mapping to TEs. Overall, for TE mapping piRNAs, the reader needs to also have a fold reduction number (50% reduction or whatever) for each of the alleles that they can grasp. Especially since it is against this fold reduction of piRNA that the TE expression will be measured against.

3\. Leading into the TE expression section, the authors should remind the reader about the total fold reduction in piRNA abundance for the three sim alleles and ask if there is a proportional increase in TE expression. Again, it would be helpful to get a single metric for fold change in TE expression across the TE bulk (perhaps for just the TE that are misregulated in the mutants stocks). The point I think the authors are trying to make is that a proportional decrease in total piRNA amounts doesn\'t lead to a proportional increase in TE expression. To make that argument, the figures as presented are not sufficient. They need to present these numbers directly in the text for bulk decrease of TE piRNAs and bulk increase for TE expression.

4\. For figure 4B, Dmel-armi vs. Dsim-armi, the scale for log2FC TE transcript abundance should be on the same level as in 4A for spnE and aub. As presented, it gives the impression that the variance for log2FC TE expression is higher for armi. Maybe scale all of them from -1 to 2?

5\. Based on Figure 4A, in the text the authors state (page 13, line 13): Strikingly, we observed no correlated changes between piRNA and mRNA pools for aub and spnE when the two transgenic rescues are compared to each other, suggesting the magnitude of changes in piRNA abundance are not sufficient to impact downstream targets.

I feel like the use of the word \"Strikingly\" is misleading. If one looks at the range of piRNA level change in the mutant vs. transgene that is equivalent in the transgene vs. transgene range, one also doesn\'t see a relationship in the mutant vs. transgene plots. So, clearly the magnitude of piRNA abundance change is not sufficient in the transgene vs. transgene contrast to reveal this relationship. The way the figure is set up, it might imply to the reader that there is a difference in the relationship between piRNA abundance and expression. But, clearly the results do support the conclusion that TE control is robust to changes in piRNA abundance in this range.

6\. Why does 4A examine Log2FC for total TE transcript abundance by 4B look at antisense transcript abundance?

7\. Regarding genic piRNAs - perhaps I don\'t follow Figure 6B, but in a direct contrast of sim vs. mel alleles, are there more genic piRNAs in one vs. the other? 6B seems to be relative to mutant, but what about vs. each other? Perhaps some clarification of this would be helpful.

\*\*\*\*\*\*\*\*\*\*

**Have all data underlying the figures and results presented in the manuscript been provided?**

Large-scale datasets should be made available via a public repository as described in the *PLOS Genetics* [data availability policy](http://journals.plos.org/plosgenetics/s/data-availability), and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer \#1: Yes

Reviewer \#2: Yes

Reviewer \#3: No: Spreadsheets for numerical data underlying graphs, and summary statistics of sRNA and RNA-seq data were not provided.

Reviewer \#4: Yes

\*\*\*\*\*\*\*\*\*\*

PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosgenetics/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).
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12 Feb 2020

Dear Dr Kelleher,

Thank you very much for submitting your Research Article entitled \'Adaptive evolution among cytoplasmic piRNA proteins leads to decreased genomic auto-immunity\' to PLOS Genetics. Your manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important problem, but raised some substantial concerns about the current manuscript. Based on the reviews, we will not be able to accept this version of the manuscript, but we would be willing to review again a much-revised version. We cannot, of course, promise publication at that time.

Should you decide to revise the manuscript for further consideration here, your revisions should address the specific points made by each reviewer. We will also require a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

If you decide to revise the manuscript for further consideration at PLOS Genetics, please aim to resubmit within the next 60 days, unless it will take extra time to address the concerns of the reviewers, in which case we would appreciate an expected resubmission date by email to <plosgenetics@plos.org>.

If present, accompanying reviewer attachments are included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our [Submission Checklist](http://journals.plos.org/plosgenetics/s/submit-now#loc-submission-checklist).

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see our [guidelines](http://journals.plos.org/plosgenetics/s/submission-guidelines#loc-materials-and-methods).

Please be aware that our [data availability policy](http://journals.plos.org/plosgenetics/s/data-availability) requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as \"data not shown\" or \"unpublished results\" in manuscripts. All points should be backed up by data provided with the submission.

While revising your submission, please upload your figure files to the [Preflight Analysis and Conversion Engine](http://pace.apexcovantage.com/) (PACE) digital diagnostic tool.  PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>.

PLOS has incorporated [Similarity Check](http://www.crossref.org/crosscheck.html), powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, use the link below and \'Revise Submission\' in the \'Submissions Needing Revision\' folder.

\[LINK\]

We are sorry that we cannot be more positive about your manuscript at this stage. Please do not hesitate to contact us if you have any concerns or questions.

Yours sincerely,

Andrea Betancourt

Guest Editor

PLOS Genetics

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

Dear Erin:

Many apologies for the delay in getting this back to you. As you noted in your letter, the revisions last time were extensive, and involved substantial reinterpretation of the results. One of the reviewers had substantial remaining concerns, so I read the manuscript and review carefully before making my recommendation.

The reviewers and I found the revised manuscript greatly improved and of broad general interest, particularly the genomic auto-immunity interpretation. I also appreciated the new, more nuanced discussion of the results. There are a few minor presentation issues picked up by the reviewer or myself. There are also a few analyses suggested by reviewer 3: please carefully consider whether these analyses would strengthen the evidence for autoimmunity. While I've suggested major revisions, most of these revisions are minor, with the possible exception of the new analysis.

Best wishes,

Andrea Betancourt

• Please clarify whether the data in Figure S3 is total piRNAs, or restricted to those that map to TEs.

• Typo in table associated with figure 4A; 'reguated'

• Consider replacing Figure 4 panels D and E with analogs of Figure 2B. If not, please improve the figure legend.

• Consider revising Table S9 so that the reader can more easily see the increase in the D. simulans sense piRNAs.

• Consider the analysis of the already available aub-iCLIP data suggested by the reviewer; I agree that, if the data are appropriate, this analysis would strengthen the evidence for promiscuous binding of mRNAs.

• Please take care to italicise 'D. melanogaster' and 'D. simulans'.

• Please note the other minor issues raised by reviewers 2 and 4.

Reviewer\'s Responses to Questions

**Comments to the Authors:**

**Please note here if the review is uploaded as an attachment.**

Reviewer \#2: The newly revised manuscript has addressed my concerns. The new analyses bridging piRNAs and genic transcripts were informative. I found only one technical error:

Figure S3B -- 2nd row 2nd column the top of the axis is cut off.

Reviewer \#3: The review is uploaded as an attachment

Reviewer \#4: This article is greatly improved for clarity and it seems the major concern this reviewer had was resolved by identifying and fixing an artifact in the previous analysis.

My only suggestion is for greater clarity in figures 4D and 4E. The represented probability distributions are estimated from the data, but they should overlay the actual data on these plots. In addition, the following values on the plots should be defined in the figure legend:

1\) What is \'s\'? It looks like the number for LogFC2 \>0, but I would recommend deleting that because it is both redundant and confusing.

2\) Please clarify that the dotted grey line is the zero point and the dotted blue line is the mean(?)/median(?)..

3\) Label the three panels in D and E both with aub, spnE and armi? I assume that is the order, but it is not 100% clear.

\*\*\*\*\*\*\*\*\*\*

**Have all data underlying the figures and results presented in the manuscript been provided?**

Large-scale datasets should be made available via a public repository as described in the *PLOS Genetics* [data availability policy](http://journals.plos.org/plosgenetics/s/data-availability), and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer \#2: Yes

Reviewer \#3: Yes

Reviewer \#4: Yes
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PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosgenetics/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).
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\* Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. \*

Dear Dr Kelleher,

Thank you very much for submitting your Research Article entitled \'Adaptive evolution among cytoplasmic piRNA proteins leads to decreased genomic auto-immunity\' to PLOS Genetics.

Thanks for your manuscript, and apologies for the delay in getting back to you. I\'ve \[AB\] now taken a careful look, and agree that the results will be of general interest to readers of Plos Genetics I do think that the manuscript suffers from a lack of clarity on a few points. None of these problems are major, but I do think a bit more polish and clarity will increase the impact of the work. I\'m recommending minor changes in order to give you an opportunity to take care of these problems, which are indeed very minor.

Abstract Line 17: stray \'t\'

p\. 8 \"Samples sizes\" =\> Sample sizes

p\. 8 Line 8: \" Because D. simulans transgenes do not exhibit significantly reduced expression when compared to D.

melanogaster (S2 Fig)\": Unless I\'ve misread Figures S2, it shows \'significantly reduced expression\' for the D simulans spnE transgene. Please clarify.

p\. 9 \"This surprising bias towards enhanced negative regulation by D. simulans is not consistent with the random segregation of TE copies during backcrossing.\"; please clarify what this means.

p\. 9, Lines 3 & 15, \"5 out of 5 TE families\": I think there are only 4 families, as Tirant appears twice.

Fig 2. Why is total TE transcript level shown for aub, rather than only sense as for the other two proteins? Non-stranded libraries? If so, that\'s fine, but please clarify. Why are sense TE piRNAs never shown?

Fig. S4\-- What do the rectangles represent- is it the range between the two? Also, it would be helpful to remind the reader of which two transgenes from figure 2A are being compared/

Please read over the supplementary figure legends, and make sure they are complete.

Please also consider mentioning the (admittedly modest) differences in piRNA biogenesis in the abstract, and consider clarifying that these do not result in global piRNA differences at the beginning of this section, as otherwise the reader is left wondering about this point.

In addition we ask that you:

Provide a striking Image with a corresponding caption to accompany your manuscript if one is available (either a new image or an existing one from within your manuscript). If this image is judged to be suitable, it may be featured on our website. Images should ideally be high resolution, eye-catching, single panel square images. For examples, please browse our [archive](http://www.plosgenetics.org/article/browse/volume). If your image is from someone other than yourself, please ensure that the artist has read and agreed to the terms and conditions of the Creative Commons Attribution License. Note: we cannot publish copyrighted images.

We hope to receive your revised manuscript within the next 30 days. If you anticipate any delay in its return, we would ask you to let us know the expected resubmission date by email to <plosgenetics@plos.org>.

You can use this link to log into the system when you are ready to submit a revised version, having first consulted our [Submission Checklist](http://journals.plos.org/plosgenetics/s/submit-now#loc-submission-checklist).

While revising your submission, please upload your figure files to the [Preflight Analysis and Conversion Engine](http://pace.apexcovantage.com/) (PACE) digital diagnostic tool. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>.

Please be aware that our [data availability policy](http://journals.plos.org/plosgenetics/s/data-availability) requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as \"data not shown\" or \"unpublished results\" in manuscripts. All points should be backed up by data provided with the submission.

PLOS has incorporated [Similarity Check](http://www.crossref.org/crosscheck.html), powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, you will need to go to the link below and \'Revise Submission\' in the \'Submissions Needing Revision\' folder.

\[LINK\]

Please let us know if you have any questions while making these revisions.

Yours sincerely,

Andrea Betancourt

Guest Editor

PLOS Genetics

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics
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14 May 2020

Dear Dr Kelleher,

We are pleased to inform you that your manuscript entitled \"Adaptive evolution among cytoplasmic piRNA proteins leads to decreased genomic auto-immunity\" has been editorially accepted for publication in PLOS Genetics. Congratulations!

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional accept, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you've already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at <plosgenetics@plos.org>.

In the meantime, please log into Editorial Manager at <https://www.editorialmanager.com/pgenetics/>, click the \"Update My Information\" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to 'Update my Information' (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about one way to make your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Andrea Betancourt

Guest Editor

PLOS Genetics

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

[www.plosgenetics.org](http://www.plosgenetics.org)

Twitter: \@PLOSGenetics

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

Comments from the reviewers (if applicable):

Dear Erin:

Thank you for the revised version of the manuscript, and especially for the increase in clarity on a few points of confusion here and there in the manuscript. I think making the mansucript easier to digest will increase the impact of the work, which is interesting and potentially very important.

Hope all is well.

Best wishes,

Andrea

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

**Data Deposition**

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the [Dryad Digital Repository](http://www.datadryad.org). As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our [website](http://journals.plos.org/plosgenetics/s/data-availability#loc-recommended-repositories).

The following link will take you to the Dryad record for your article, so you won\'t have to re‐enter its bibliographic information, and can upload your files directly: 

<http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-19-01131R3>

More information about depositing data in Dryad is available at <http://www.datadryad.org/depositing>. If you experience any difficulties in submitting your data, please contact <help@datadryad.org> for support.

Additionally, please be aware that our [data availability policy](http://journals.plos.org/plosgenetics/s/data-availability) requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

**Press Queries**

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper\'s publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there\'s anything the journal should know or you\'d like more information, please get in touch via <plosgenetics@plos.org>.
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PGENETICS-D-19-01131R3

Adaptive evolution among cytoplasmic piRNA proteins leads to decreased genomic auto-immunity

Dear Dr Kelleher,

We are pleased to inform you that your manuscript entitled \"Adaptive evolution among cytoplasmic piRNA proteins leads to decreased genomic auto-immunity\" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article\'s publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Jason Norris

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN \| United Kingdom

<plosgenetics@plos.org> \| +44 (0) 1223-442823

[plosgenetics.org](http://plosgenetics.org) \| Twitter: \@PLOSGenetics

[^1]: The authors have declared that no competing interests exist.
